CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0022
-0.0004 (-15.38%)
Aug 1, 2025, 11:20 AM EDT
Accolade Market Cap
CannaPharmaRX has a market cap or net worth of $1.71 million as of August 1, 2025. Its market cap has decreased by -83.28% in one year.
Market Cap
1.71M
Enterprise Value
19.10M
Revenue
1.13M
Ranking
n/a
PE Ratio
1.63
Stock Price
$0.00
Market Cap Chart
Since October 29, 1999, CannaPharmaRX's market cap has decreased from 27.64M to 1.71M, a decrease of -93.83%. That is a compound annual growth rate of -10.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 1.71M | -67.90% |
| Dec 31, 2024 | 5.32M | 622.75% |
| Dec 29, 2023 | 735.50K | -71.38% |
| Dec 30, 2022 | 2.57M | 62.24% |
| Dec 31, 2021 | 1.58M | -92.76% |
| Dec 31, 2020 | 21.89M | -52.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 794.80M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 586.78M |
| Glass House Brands | 435.01M |
| Northwest Biotherapeutics | 372.10M |
| CytoDyn | 341.59M |